Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.1, expectations were $-1.2.

Related Keywords

United States ,Italy ,Canada ,Germany ,Japan ,Spain ,Christine Lindenboom ,Pushkal Garg ,Kostas Biliouris ,Ellie Merle ,Akshay Vaishnaw ,Jeff Poulton ,Paul Matteis ,Yvonne Greenstreet ,Tolga Tanguler ,Novartis ,Fastest Growing Companies ,Nasdaq ,Alnylam Pharmaceuticals Inc ,Corporate Communications At Alnylam ,Alnylam Pharmaceuticals ,Call Transcript February ,Senior Vice President ,Investor Relations ,Corporate Communications ,Chief Executive Officer ,Chief Commercial Officer ,Chief Medical Officer ,Chief Financial ,Chief Innovation ,Safe Harbor ,Private Securities Litigation Reform Act ,Growinge Commerce Companies ,Dating Sites ,Ritu Baral ,